Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
   
Ask the Experts About

Choosing Your MedsChoosing Your Meds
          
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  
  • Email Email
  • Glossary Glossary


HAART
Apr 21, 2007

is there a rationale for giving Reyataz and Lexiva together boosted with Norvir?

Response from Dr. Young

Thanks for your post.

The use of two protease inhibitors (in this case, atazanavir and fosamprenavir) with ritonavir boosting would be for very selected cases where there was significant drug resistance. Combos like this should be used only be experts, since there are a number of issues with drug-drug interactions that could cause unexpected differences in drug levels.

Given the availability of more potent PIs, like tipranavir (Aptivus) and darunavir (Prezista), as well as early access programs for the new classes of HIV medications-- CCR5- and integrase inhibitors, the need to use such untested combinations (dual boosted PIs) should be declining. Indeed, in our clinic, there are scant patients remaining on this type of regimen.

Hope this helps. BY



Previous
AZT anemia
Next
sgpt help urgent

  
  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS


 
Advertisement



Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement